NCT01350934View on ClinicalTrials.gov

A Study to Evaluate Alendronate Sodium /Vitamin D3 Combination Tablets(FOSAMAX PLUS) Versus Calcitriol in the Treatment of Osteoporosis in Postmenopausal Women in China (MK-0217A-264)

PHASE4CompletedINTERVENTIONAL

Enrollment

219

Participants

Timeline

Start Date

June 19, 2011

Primary Completion Date

January 10, 2013

Study Completion Date

January 10, 2013

Conditions

Osteoporosis, Postmenopausal

Interventions

DRUG

alendronate 70-mg/vitamin D3 5600 IU combination tablet (Fosamax Plus)

one combination tablet once weekly

DRUG

Calcitriol

0.25 μg once daily orally

DIETARY_SUPPLEMENT

Calcium 500 mg

one 500 mg tablet once daily

All Listed Sponsors

lead

Organon and Co

INDUSTRY

NCT01350934 - A Study to Evaluate Alendronate Sodium /Vitamin D3 Combination Tablets(FOSAMAX PLUS) Versus Calcitriol in the Treatment of Osteoporosis in Postmenopausal Women in China (MK-0217A-264) | Biotech Hunter | Biotech Hunter